T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited to the pancreas and size 2–4 cm T3 Tumor limited to the pancreas and size >4 cm or invading duodenum or bile duct T4 Tumor ...
Jennifer Chan, MD, MPH, discussed the recent FDA approval of cabozantinib in pancreatic and extrapancreatic neuroendocrine tumors.
Health and Me on MSN20h
FDA Approves Cabozantinib For Neuroendocrine TumorsThe approval came on the bases of the results from the phase 3 CABINET study. The study compared cabozantinib to a placebo in ...
A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback